AQST EBITDA Growth
Aquestive Therapeutics Inc · EBITDA Growth
AQST EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-29.25%period ending
AQST TTM EBITDA YoY % (-1772.78% → -29.25%)
Year-over-year change
High-resolution chart · PNG
AQST ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -29.2494% | |
| -40.6533% | |
| -148.4821% | |
| -181.8885% | |
| -306.8443% | |
| -114.4159% | |
| -2,353.6833% | |
| -282.7383% | |
| 5.961% | |
| 17.2387% | |
| 102.9841% | |
| 91.1735% | |
| 76.5468% | |
| 55.2928% | |
| 12.1078% | |
| -55.1743% | |
| -30.1923% | |
| -35.9123% | |
| -15.0284% | |
| -2.5847% | |
| -13.6023% | |
| 37.8453% | |
| 27.3972% | |
| 39.5757% | |
| 33.0227% | |
| 21.1298% | |
| -6.872% | |
| -21.218% | |
| -137.4378% | |
| -938.1245% | |
| -1,772.7785% |